Diomed Holdings, Inc.

Device firm reports 39% increase in revenues

Published in Biotech Law Weekly, June 4th, 2004

Diomed Holdings, Inc., (DIO), a developer and marketer of minimally invasive medical technologies, including its patented EndoVenous Laser Treatment (EVLT) of varicose veins, announced financial results for the first quarter ended March 31, 2004.

In the first quarter of 2004, Diomed delivered revenue of $2.9 million, a 39% increase over Q1 2003. Revenue from the EVLT product line increased 53% over the same period last year, including growth of more than 100% in disposable procedure products.

"Diomed continued its strong pace through the first quarter of 2004," stated James Wylie, president and CEO of Diomed Holdings, Inc., "Our first quarter...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2004-06-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry